|
|
|
|
LEADER |
09144nma a2202905 u 4500 |
001 |
EB002049536 |
003 |
EBX01000000000000001193202 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
220822 ||| eng |
020 |
|
|
|a books978-3-0365-0163-5
|
020 |
|
|
|a 9783036501628
|
020 |
|
|
|a 9783036501635
|
100 |
1 |
|
|a Narzisi, Antonio
|
245 |
0 |
0 |
|a Advances in Autism Research
|h Elektronische Ressource
|
260 |
|
|
|a Basel, Switzerland
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2021
|
300 |
|
|
|a 1 electronic resource (400 p.)
|
653 |
|
|
|a HMD
|
653 |
|
|
|a systematic review
|
653 |
|
|
|a accuracy
|
653 |
|
|
|a cognition
|
653 |
|
|
|a preschool teachers
|
653 |
|
|
|a persuasive text writing
|
653 |
|
|
|a bipolar disorder
|
653 |
|
|
|a assessment
|
653 |
|
|
|a challenging behaviors
|
653 |
|
|
|a insight
|
653 |
|
|
|a affiliative behavior
|
653 |
|
|
|a postural balance
|
653 |
|
|
|a suicidal ideation
|
653 |
|
|
|a wearable technologies
|
653 |
|
|
|a literature review
|
653 |
|
|
|a epilepsy
|
653 |
|
|
|a mouse social behavior
|
653 |
|
|
|a short sensory profile (SSP)
|
653 |
|
|
|a sensitization
|
653 |
|
|
|a moderators and mediators of intervention.
|
653 |
|
|
|a perspective-taking
|
653 |
|
|
|a precise medicine
|
653 |
|
|
|a telehealth
|
653 |
|
|
|a action observation
|
653 |
|
|
|a gastrointestinal
|
653 |
|
|
|a compulsion
|
653 |
|
|
|a attention deficit and hyperactivity disorder
|
653 |
|
|
|a social interaction
|
653 |
|
|
|a obsession
|
653 |
|
|
|a problem behaviors
|
653 |
|
|
|a neuroinflammation
|
653 |
|
|
|a schizophrenia
|
653 |
|
|
|a action prediction
|
653 |
|
|
|a PAI-1
|
653 |
|
|
|a early intensive behavioral intervention
|
653 |
|
|
|a side effects
|
653 |
|
|
|a ABA
|
653 |
|
|
|a regression
|
653 |
|
|
|a sensory experience questionnaire (SEQ)
|
653 |
|
|
|a intellectual disability
|
653 |
|
|
|a dopamine
|
653 |
|
|
|a Draw-a-Man
|
653 |
|
|
|a Gulf
|
653 |
|
|
|a Gilles de la Tourette
|
653 |
|
|
|a COSMIN
|
653 |
|
|
|a THC
|
653 |
|
|
|a suicidal attempts
|
653 |
|
|
|a cortisol
|
653 |
|
|
|a priors
|
653 |
|
|
|a validity
|
653 |
|
|
|a proprioception
|
653 |
|
|
|a 2019-nCoV
|
653 |
|
|
|a belief
|
653 |
|
|
|a p-cresol
|
653 |
|
|
|a feeding problems
|
653 |
|
|
|a metabolomics
|
653 |
|
|
|a infant screening
|
653 |
|
|
|a art
|
653 |
|
|
|a GAD65
|
653 |
|
|
|a parents
|
653 |
|
|
|a prevalence estimate
|
653 |
|
|
|a screening
|
653 |
|
|
|a technology
|
653 |
|
|
|a IVR
|
653 |
|
|
|a coronavirus
|
653 |
|
|
|a n/a
|
653 |
|
|
|a high-risk infants
|
653 |
|
|
|a sensory responsiveness
|
653 |
|
|
|a social cognition
|
653 |
|
|
|a false positive report probability (FPRP)
|
653 |
|
|
|a infants
|
653 |
|
|
|a TAS-20
|
653 |
|
|
|a Early Start Denver Model
|
653 |
|
|
|a challenging behavior
|
653 |
|
|
|a health system
|
653 |
|
|
|a cytokines
|
653 |
|
|
|a adolescence
|
653 |
|
|
|a human figure drawings
|
653 |
|
|
|a BOT-2
|
653 |
|
|
|a infection
|
653 |
|
|
|a Europe
|
653 |
|
|
|a behavioral intervention
|
653 |
|
|
|a Asperger syndrome
|
653 |
|
|
|a blood–brain barrier
|
653 |
|
|
|a context
|
653 |
|
|
|a COVID-19
|
653 |
|
|
|a vision
|
653 |
|
|
|a high-functioning autism
|
653 |
|
|
|a longitudinal
|
653 |
|
|
|a cannabidivarin
|
653 |
|
|
|a group activity
|
653 |
|
|
|a hypothalamus
|
653 |
|
|
|a study design
|
653 |
|
|
|a psychopathology
|
653 |
|
|
|a Genome-Wide Association Studies (GWAS)
|
653 |
|
|
|a Autism Spectrum Disorder (ASD)
|
653 |
|
|
|a dental care
|
653 |
|
|
|a motor performance skills
|
653 |
|
|
|a surveillance review
|
653 |
|
|
|a joint attention
|
653 |
|
|
|a self-efficacy
|
653 |
|
|
|a sleep
|
653 |
|
|
|a amygdala
|
653 |
|
|
|a self-awareness
|
653 |
|
|
|a social perception
|
653 |
|
|
|a ICT
|
653 |
|
|
|a machine learning
|
653 |
|
|
|a imitation
|
653 |
|
|
|a biomarker discovery
|
653 |
|
|
|a skills
|
653 |
|
|
|a cannabidiol
|
653 |
|
|
|a language acquisition
|
653 |
|
|
|a identify
|
653 |
|
|
|a social-cognitive development
|
653 |
|
|
|a social skills intervention
|
653 |
|
|
|a level 1 and level 2 screening tools
|
653 |
|
|
|a adulthood
|
653 |
|
|
|a meta-analysis
|
653 |
|
|
|a semantic features
|
653 |
|
|
|a communication
|
653 |
|
|
|a motion analysis
|
653 |
|
|
|a early intervention
|
653 |
|
|
|a medical procedures
|
653 |
|
|
|a risk
|
653 |
|
|
|a knowledge
|
653 |
|
|
|a central coherence
|
653 |
|
|
|a disruptive behavior disorders
|
653 |
|
|
|a neurodevelopmental disorders
|
653 |
|
|
|a regressive autism
|
653 |
|
|
|a eye tracking
|
653 |
|
|
|a Bayesian false-discovery probability (BFDP)
|
653 |
|
|
|a video signal processing
|
653 |
|
|
|a autonomic nervous system
|
653 |
|
|
|a RCT
|
653 |
|
|
|a cerebrospinal fluid
|
653 |
|
|
|a grammatical comprehension
|
653 |
|
|
|a language profiles
|
653 |
|
|
|a empathy
|
653 |
|
|
|a biomarker
|
653 |
|
|
|a AQ
|
653 |
|
|
|a social behavior
|
653 |
|
|
|a migration
|
653 |
|
|
|a alexithymia
|
653 |
|
|
|a Neurosciences / bicssc
|
653 |
|
|
|a autism
|
653 |
|
|
|a neurodevelopment
|
653 |
|
|
|a motor development
|
653 |
|
|
|a self-motion
|
653 |
|
|
|a cross-cultural generalisability
|
653 |
|
|
|a early screening
|
653 |
|
|
|a sensorimotor integration
|
653 |
|
|
|a theory of mind
|
653 |
|
|
|a early intensive intervention
|
653 |
|
|
|a PEERS®
|
653 |
|
|
|a autism spectrum disorder (ASD)
|
653 |
|
|
|a mental health prevention
|
653 |
|
|
|a microbiome
|
653 |
|
|
|a autism spectrum disorders
|
653 |
|
|
|a adults
|
653 |
|
|
|a employment
|
653 |
|
|
|a visual impairment
|
653 |
|
|
|a autism in adulthood
|
653 |
|
|
|a PRISMA
|
653 |
|
|
|a depression
|
653 |
|
|
|a RewP
|
653 |
|
|
|a stereotypical behaviors
|
653 |
|
|
|a cannabinoids
|
653 |
|
|
|a TSIA
|
653 |
|
|
|a ASD
|
653 |
|
|
|a diagnosis
|
653 |
|
|
|a predictors
|
653 |
|
|
|a Medicine / bicssc
|
653 |
|
|
|a comorbidity
|
653 |
|
|
|a prion
|
653 |
|
|
|a toddlers
|
653 |
|
|
|a sign language
|
653 |
|
|
|a wearable sensors
|
653 |
|
|
|a stress
|
653 |
|
|
|a immersive virtual reality
|
653 |
|
|
|a child and adolescent psychiatry
|
653 |
|
|
|a autism spectrum disorder
|
653 |
|
|
|a oxytocin
|
653 |
|
|
|a broader autism phenotype
|
653 |
|
|
|a neuroimaging
|
653 |
|
|
|a reward response
|
653 |
|
|
|a drawings maturity
|
653 |
|
|
|a antibodies
|
653 |
|
|
|a intervention
|
653 |
|
|
|a adults and adolescents
|
653 |
|
|
|a developmental language disorder
|
653 |
|
|
|a frontal EEG alpha asymmetry
|
653 |
|
|
|a EEG
|
653 |
|
|
|a language
|
653 |
|
|
|a early detection
|
653 |
|
|
|a preconception risk factor
|
653 |
|
|
|a attention to detail
|
653 |
|
|
|a anxiety
|
653 |
|
|
|a autistic traits
|
653 |
|
|
|a ERP
|
653 |
|
|
|a experience
|
653 |
|
|
|a First Year Inventory
|
653 |
|
|
|a word learning
|
653 |
|
|
|a social impairment
|
653 |
|
|
|a psychosis
|
653 |
|
|
|a sensory profile
|
653 |
|
|
|a autistic-like features
|
653 |
|
|
|a developmental trajectories
|
653 |
|
|
|a executive functions
|
653 |
|
|
|a hyperactivity
|
653 |
|
|
|a oral health
|
700 |
1 |
|
|a Narzisi, Antonio
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
024 |
8 |
|
|a 10.3390/books978-3-0365-0163-5
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/76388
|z DOAB: description of the publication
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/book/3823
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 400
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 333
|
082 |
0 |
|
|a 380
|
082 |
0 |
|
|a 304
|
082 |
0 |
|
|a 330
|
082 |
0 |
|
|a 800
|
082 |
0 |
|
|a 140
|
082 |
0 |
|
|a 700
|
082 |
0 |
|
|a 600
|
520 |
|
|
|a This book represents one of the most up-to-date collections of articles on clinical practice and research in the field of Autism Spectrum Disorders (ASD). The scholars who contributed to this book are experts in their field, carrying out cutting edge research in prestigious institutes worldwide (e.g., Harvard Medical School, University of California, MIND Institute, King’s College, Karolinska Institute, and many others). The book addressed many topics, including (1) The COVID-19 pandemic; (2) Epidemiology and prevalence; (3) Screening and early behavioral markers; (4) Diagnostic and phenotypic profile; (5) Treatment and intervention; (6) Etiopathogenesis (biomarkers, biology, and genetic, epigenetic, and risk factors); (7) Comorbidity; (8) Adulthood; and (9) Broader Autism Phenotype (BAP). This book testifies to the complexity of performing research in the field of ASD. The published contributions underline areas of progress and ongoing challenges in which more certain data is expected in the coming years. It would be desirable that experts, clinicians, researchers, and trainees could have the opportunity to read this updated text describing the challenging heterogeneity of Autism Spectrum Disorder.
|